EvogeneEVGN

13F holders, Q1 2026 (March 31)
15holders −3
2new positions
5sold out
$0.77avg. 13F price*

At the end of Q1 2026, 15 institutions reported holding Evogene Ltd. (EVGN) in their 13F filings, down 3 from Q4 2025. 2 opened new positions and 5 sold out. The largest holders were Armistice Capital, LLC ($352K), Jane Street Group, LLC ($14K) and XTX Topco Ltd ($10K).

Company
Evogene Ltd.
CUSIP
M4119S187
Latest filing quarter
Q2 2026

History

Number of 13F holders

05101520 Q3 2024: 14Q3 2024Q4 2024: 15Q4 2024Q1 2025: 16Q1 2025Q2 2025: 16Q2 2025Q3 2025: 14Q3 2025Q4 2025: 18Q4 2025Q1 2026: 15Q1 2026Q2 2026: 13Q2 2026

Total Exit/New Position Q4 2025 → Q1 2026

InstitutionsTotal Value
New Positions2$361K
Exits5$99K

All 13F filers, Q4 2025 → Q1 2026: 474,207 shares bought and 125,330 shares sold, net +348,877 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 15 holders

Armistice Capital, LLC 0.01% New 456,587 $352K
Jane Street Group, LLC 0.00% Reduce -51.2% 18,500 $14K
XTX Topco Ltd 0.00% Reduce -43.9% 12,721 $10K
Two Sigma Securities, LLC 0.00% New 12,465 $10K
Daytona Street Capital LLC 0.01% No change 9,586 $8K
BNP Paribas Financial Markets 0.00% Reduce -9.9% 9,124 $7K
UBS Group AG 0.00% Add +430.7% 6,352 $5K
Morgan Stanley 0.00% Reduce -57.5% 3,851 $3K
Steward Partners Investment Advisory, LLC 0.00% No change 505 $389
Federation des caisses Desjardins du Quebec 0.00% No change 500 $385
Tradewinds Capital Management, LLC 0.00% No change 131 $101
Osaic Holdings, Inc. 0.00% Reduce -33.3% 100 $77
SBI Securities Co., Ltd. 0.00% No change 72 $55
SHP Wealth Management 0.00% No change 65 $50
Royal Bank of Canada 0.00% No change 42 $0

"% of holder's portfolio" is EVGN's weight in each manager's 13F, not the share of Evogene Ltd. the manager owns.